Literature DB >> 20117502

Critical limb ischemia.

Vinit N Varu1, Melissa E Hogg, Melina R Kibbe.   

Abstract

Critical limb ischemia (CLI) continues to be a significantly morbid disease process for the aging population. Rigid guidelines for the management of patients with CLI are inappropriate due to the complexities that are involved in optimally treating these patients. A thin line exists in the decision process between medical management vs surgical management by revascularization or amputation, and the perception of "success" in this patient population is evolving. This review explores these issues and examines the challenges the treating physician will face when managing the care of patients with CLI. The epidemiology and natural history of CLI is discussed, along with the pathophysiology of the disease process. A review of the literature in regards to the different treatment modalities is presented to help the physician optimize therapy for patients with CLI. New scoring systems to help predict outcomes in patients with CLI undergoing revascularization or amputation are discussed, and an overview of the current status of patient-oriented outcomes is provided. Finally, we briefly examine emerging therapies for the treatment of CLI and provide an algorithm to help guide the practicing physician on how to approach the critically ischemic limb with regard to the complicated issues surrounding these patients. Published by Mosby, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20117502     DOI: 10.1016/j.jvs.2009.08.073

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  86 in total

1.  Critical limb ischemia.

Authors:  Paolo Gresele; Chiara Busti; Tiziana Fierro
Journal:  Intern Emerg Med       Date:  2011-10       Impact factor: 3.397

2.  Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data.

Authors:  Kunihiro Matsushita; Shoshana H Ballew; Josef Coresh; Hisatomi Arima; Johan Ärnlöv; Massimo Cirillo; Natalie Ebert; Jade S Hiramoto; Heejin Kimm; Michael G Shlipak; Frank L J Visseren; Ron T Gansevoort; Csaba P Kovesdy; Varda Shalev; Mark Woodward; Florian Kronenberg
Journal:  Lancet Diabetes Endocrinol       Date:  2017-07-14       Impact factor: 32.069

3.  Phase Ib Safety, Two-Dose Study of MultiGeneAngio in Patients with Chronic Critical Limb Ischemia.

Authors:  Moshe Y Flugelman; Moshe Halak; Boris Yoffe; Jacob Schneiderman; Chen Rubinstein; Allan-Isaac Bloom; Eran Weinmann; Ilya Goldin; Victor Ginzburg; Olga Mayzler; Aaron Hoffman; Belly Koren; Diana Gershtein; Michal Inbar; Marina Hutoran; Adili Tsaba
Journal:  Mol Ther       Date:  2017-01-28       Impact factor: 11.454

4.  Non-contrast-enhanced MR angiography in critical limb ischemia: performance of quiescent-interval single-shot (QISS) and TSE-based subtraction techniques.

Authors:  Mustafa A Altaha; Jeffrey D Jaskolka; Kongteng Tan; Manuela Rick; Peter Schmitt; Ravi J Menezes; Bernd J Wintersperger
Journal:  Eur Radiol       Date:  2016-06-28       Impact factor: 5.315

5.  Fatigability and functional performance among older adults with low-normal ankle-brachial index: Cross-sectional findings from the Baltimore Longitudinal Study of Aging.

Authors:  Pablo Martinez-Amezcua; Kunihiro Matsushita; Eleanor M Simonsick; Luigi Ferrucci; Jennifer A Schrack
Journal:  Atherosclerosis       Date:  2018-03-22       Impact factor: 5.162

6.  2017 ACC/AHA blood pressure classification and incident peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Yifei Lu; Shoshana H Ballew; Hirofumi Tanaka; Moyses Szklo; Gerardo Heiss; Josef Coresh; Kunihiro Matsushita
Journal:  Eur J Prev Cardiol       Date:  2019-07-30       Impact factor: 7.804

7.  Gender-related variation in the clinical presentation and outcomes of critical limb ischemia.

Authors:  Caroline E McCoach; Ehrin J Armstrong; Satinder Singh; Usman Javed; David Anderson; Khung Keong Yeo; Gregory G Westin; Nasim Hedayati; Ezra A Amsterdam; John R Laird
Journal:  Vasc Med       Date:  2013-02       Impact factor: 3.239

Review 8.  Current Status of Arterial Revascularization for the Treatment of Critical Limb Ischemia in Infrainguinal Atherosclerotic Disease.

Authors:  Ahmet Yuksel; Yusuf Velioglu; Mustafa Cagdas Cayir; Gencehan Kumtepe; Orcun Gurbuz
Journal:  Int J Angiol       Date:  2018-01-22

9.  Expansion and angiogenic potential of mesenchymal stem cells from patients with critical limb ischemia.

Authors:  Luke Brewster; Scott Robinson; Ruoya Wang; Sarah Griffiths; Haiyan Li; Alexandra Peister; Ian Copland; Todd McDevitt
Journal:  J Vasc Surg       Date:  2016-02-24       Impact factor: 4.268

10.  A phase I study of human cord blood-derived mesenchymal stem cell therapy in patients with peripheral arterial occlusive disease.

Authors:  Shin-Seok Yang; Na-Ri Kim; Kwang-Bo Park; Young-Soo Do; Kyounghwan Roh; Kyung-Sun Kang; Dong-Ik Kim
Journal:  Int J Stem Cells       Date:  2013-05       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.